fda warning peptides bpc-157 unapproved Approval Status: Is It Approved for Human Use? An FDA advisory committee is

Excessive angiogenesis during early surgical healing can complicate scar formation

BPC-157 works by activating pathways your body uses to repair itself: increasing blood flow, reducing inflammation, and stimulating the production of collagen and growth factors that rebuild damaged tissue

RT indicates the right side and LT indicates the left side

Does BPC-157 reduce scarring

Ethics declarations Ethics approval and consent to participate The study protocol was approved by the ethics committee of Guilan University of Medical Sciences (IR.GUMS.REC.1400.197) in accordance with the World Medical Associations code of ethics (Declaration of Helsinki, revised in Brazil 2013), and registered at an ICMJE and WHO recognized registry of clinical trials (www.irct.ir) at 28/08/2021 (registration number: IRCT20200920048782N1)